Patients with both type 2 diabetes (T2D) and obesity, who have a lower diabetes severity, as characterized by the individualized metabolic surgery (IMS) scoring system, achieve better weight loss ...
In a recent study published in eClinicalMedicine, researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes (T2D) based on their individualized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results